Amphastar Pharmaceuticals (AMPH) stock price, revenue and financials

View Company

+0.55 (+2.31%)

$1.1 B

AMPH Mkt cap, 13-Feb-2019

$75.5 M

Amphastar Pharmaceuticals Revenue Q3, 2018

Amphastar Pharmaceuticals Gross profit (Q3, 2018)29.3 M

Amphastar Pharmaceuticals Gross profit margin (Q3, 2018), %38.7%

Amphastar Pharmaceuticals Net income (Q3, 2018)1.6 M

Amphastar Pharmaceuticals EBIT (Q3, 2018)2.6 M

Amphastar Pharmaceuticals Cash, 30-Sep-201868.7 M

Amphastar Pharmaceuticals Revenue

Amphastar Pharmaceuticals revenue was $240.18 m in FY, 2017

Embed Graph

Amphastar Pharmaceuticals Revenue Breakdown

Business Segment

Embed Graph

Amphastar Pharmaceuticals revenue breakdown by business segment: 5.9% from Active Pharmaceutical Ingredients and 94.1% from Finished pharmaceutical products

Annual

USD	FY, 2014	FY, 2015	FY, 2016	FY, 2017
Revenue	210.5m	251.5m	255.2m	240.2m
Revenue growth, %		20%	1%
Cost of goods sold	159.2m	174.2m	151.0m	149.4m
Gross profit	51.3m	77.3m	104.2m	90.8m
Gross profit Margin, %	24%	31%	41%	38%
Sales and marketing expense	5.6m
R&D expense	28.4m	37.1m	41.2m	43.4m
General and administrative expense	34.8m	41.5m	41.8m	44.5m
Operating expense total	68.8m	84.2m	88.5m	91.7m
EBIT	(18.0m)	(6.9m)	15.7m	(895.0k)
EBIT margin, %	(9%)	(3%)	6%	0%
Interest expense	609.0k	987.0k	1.0m	826.0k
Interest income	243.0k	315.0k	270.0k	425.0k
Pre tax profit	(18.1m)	(10.4m)	14.9m	1.6m
Income tax expense	(7.4m)	(7.6m)	4.4m	(2.9m)
Net Income	(10.7m)	(2.8m)	10.5m	4.5m

Source: SEC Filings

Quarterly

USD	Q2, 2014	Q3, 2014	Q1, 2015	Q2, 2015	Q3, 2015	Q1, 2016	Q2, 2016	Q3, 2016	Q1, 2017	Q2, 2017	Q3, 2017	Q1, 2018	Q2, 2018	Q3, 2018
Revenue	49.0m	59.7m	56.9m	53.9m	63.9m	59.4m	68.0m	64.2m	56.7m	65.2m	57.9m	58.4m	71.0m	75.5m
Cost of goods sold	34.0m	47.9m	43.6m	40.5m	46.3m	34.5m	36.3m	36.6m	33.8m	38.4m	37.3m	41.3m	44.9m	46.3m
Gross profit	15.0m	11.8m	13.3m	13.3m	17.6m	24.9m	31.7m	27.6m	22.8m	26.7m	20.6m	17.1m	26.2m	29.3m
Gross profit Margin, %	31%	20%	23%	25%	28%	42%	47%	43%	40%	41%	36%	29%	37%	39%
R&D expense	6.0m	8.6m	6.6m	10.7m	11.1m	8.4m	10.5m	9.7m	11.3m	10.7m	10.0m	14.3m	15.5m	11.3m
General and administrative expense	8.6m	9.6m	12.5m	11.3m	9.0m	10.9m	9.5m	10.8m	11.3m	12.2m	11.7m	11.0m	11.7m	13.4m
Operating expense total	16.2m	19.6m	20.5m	23.6m	21.3m	20.8m	21.4m	21.8m	21.4m	24.6m	23.5m	27.0m	29.0m	26.7m
EBIT	(1.2m)	(7.8m)	(7.3m)	(10.3m)	(3.7m)	4.1m	10.3m	5.8m	1.4m	2.2m	(2.8m)	(9.9m)	(2.9m)	2.6m
EBIT margin, %	(2%)	(13%)	(13%)	(19%)	(6%)	7%	15%	9%	2%	3%	(5%)	(17%)	(4%)	3%
Interest expense	476.0k	504.0k	341.0k	210.0k	232.0k	384.0k	305.0k	281.0k	191.0k	237.0k	264.0k	18.0k	100.0k	124.0k
Interest income	32.0k	94.0k	92.0k	65.0k	83.0k	74.0k	50.0k	63.0k	91.0k wdxefcqufszuzezftuxetqsqxt	87.0k	124.0k	124.0k	106.0k	105.0k
Pre tax profit	(1.9m)	(8.0m)	(6.2m)	(10.2m)	(4.3m)	3.8m	9.8m	6.0m	1.5m	3.2m	(2.0m)	(9.0m)	(4.1m)	2.6m
Income tax expense	(696.0k)	(2.6m)	(5.5m)	(3.6m)	(1.3m)	1.3m	2.9m	2.1m	611.0k	1.2m	(2.2m)	(1.8m)	(1.3m)	958.0k
Net Income	(1.2m)	(5.4m)	(665.0k)	(6.6m)	(3.0m)	2.5m	6.9m	3.9m	893.0k	2.0m	175.0k	(7.2m)	(2.8m)	1.6m

Source: SEC Filings

Annual

usd	Y, 2012	Y, 2013	FY, 2014	FY, 2015	FY, 2016	FY, 2017
Cash	50.2m	53.6m	67.8m	66.1m	72.4m	65.6m
Accounts Receivable			22.9m	33.2m	26.8m	36.0m
Inventories					118.4m	63.6m
Current Assets			198.0m	175.9m	184.1m	187.8m
PP&E			138.3m	142.2m	152.9m	185.3m
Goodwill			42.6m	39.9m	50.3m	45.1m
Total Assets			389.4m	390.1m	427.7m	454.7m
Accounts Payable			10.2m	13.9m	16.2m	57.6m
Current Liabilities			62.6m	60.0m	60.6m	67.2m
Total Liabilities					98.5m	117.3m
Additional Paid-in Capital			220.7m	247.8m	283.1m	313.9m
Retained Earnings			63.1m	60.3m	70.9m	76.2m
Total Equity				295.5m	329.3m	337.3m
Financial Leverage				1.3 x	1.3 x	1.3 x

Quarterly

USD	Q2, 2014	Q3, 2014	Q1, 2015	Q2, 2015	Q3, 2015	Q1, 2016	Q2, 2016	Q3, 2016	Q1, 2017	Q2, 2017	Q3, 2017	Q1, 2018	Q2, 2018	Q3, 2018
Cash	64.1m	72.9m	68.6m	74.5m					76.8m	82.5m	66.9m	54.5m	48.1m	68.7m
Accounts Receivable	18.6m	26.6m	21.7m	19.8m	25.0m	23.1m	23.1m	26.6m	25.9m	24.1m	24.2m	31.9m	41.3m	43.8m
Inventories	106.0m	88.1m	84.9m	80.2m	72.4m	82.2m	88.3m	90.7m	78.1m	74.5m	69.6m	62.8m	61.7m	65.4m
Current Assets	214.2m	215.2m	202.6m	203.9m	199.1m	173.4m	181.3m	190.2m	191.4m	193.6m	176.5m	174.0m	169.9m	194.8m
PP&E	134.0m	134.1m	138.3m	139.3m	141.2m	144.7m	148.6m	152.0m	157.4m	161.7m	173.0m	191.9m	198.2m	202.5m
Goodwill	39.3m	43.2m	41.3m	40.9m	40.5m	44.0m	43.3m	51.7m	46.0m	45.9m	45.7m	44.9m	43.5m	42.7m
Total Assets	397.3m	401.1m	396.5m	398.9m	395.0m	395.0m	408.6m	428.8m	435.6m	444.0m	437.8m	449.8m	451.6m	480.6m
Accounts Payable	17.8m	10.0m	18.9m	18.4m	12.3m	18.6m	18.8m	13.4m	19.3m	14.9m	9.6m	58.5m	67.1m	76.4m
Current Liabilities	56.3m	63.1m	72.1m	69.4m	70.7m	64.9m	65.7m	60.8m	72.9m	63.7m	57.4m	72.5m	87.6m	96.6m
Total Liabilities	109.5m	118.0m	117.2m	113.7m	111.2m	98.4m	101.1m	100.4m	110.1m	110.7m	107.1m	122.7m	131.1m	139.4m
Additional Paid-in Capital	217.0m	219.3m	223.3m	236.7m	240.7m	250.7m	258.8m	276.5m	285.4m	299.1m	303.2m	316.7m	322.4m	330.3m
Retained Earnings	71.0m	65.6m	62.4m	55.8m	52.8m	62.8m	69.7m	73.6m	72.6m	74.6m	74.8m	69.6m	66.8m	65.6m
Total Equity				285.3m	283.8m	296.6m	307.5m	328.5m	325.6m	333.3m	330.7m	327.1m	320.5m	341.3m
Financial Leverage				1.4 x	1.4 x	1.3 x	1.3 x	1.3 x	1.3 x	1.3 x	1.3 x	1.4 x	1.4 x	1.4 x

Annual

usd	FY, 2014	FY, 2015	FY, 2016	FY, 2017
Net Income	(10.7m)	(2.8m)	10.5m	4.5m
Depreciation and Amortization			12.0m	12.6m
Accounts Receivable	1.2m		6.4m	(8.1m)
Inventories	9.1m		(9.7m)	18.7m
Accounts Payable	7.0m			6.7m
Cash From Operating Activities	14.2m	(1.8m)	38.6m	39.2m
Purchases of PP&E	(18.7m)
Cash From Investing Activities	(39.8m)		(39.5m)	(38.8m)
Long-term Borrowings	(8.2m)		(14.7m)	(9.7m)
Cash From Financing Activities	32.1m		7.1m	(7.7m)
Interest Paid	2.6m
Income Taxes Paid	436.0k		3.4m	4.9m

Quarterly

USD	Q2, 2014	Q3, 2014	Q1, 2015	Q2, 2015	Q3, 2015	Q1, 2016	Q2, 2016	Q3, 2016	Q1, 2017	Q2, 2017	Q3, 2017	Q1, 2018	Q2, 2018	Q3, 2018
Net Income	(2.8m)	(8.2m)	(665.0k)	(7.3m)	(10.3m)	2.5m	9.4m	13.3m	893.0k	2.9m	3.0m	(7.2m)	(10.0m)	(8.4m)
Depreciation and Amortization					8.5m	2.9m	6.0m	9.0m	3.1m	6.2m	9.4m	3.2m	6.6m	10.4m
Accounts Receivable	6.0m	(2.0m)	21.7m	2.5m	(2.7m)	10.2m	10.2m	6.8m	920.0k	2.8m	2.9m	4.6m	(5.2m)	(7.9m)
Inventories	(14.8m)	1.6m		564.0k	8.5m	(10.8m)	(17.4m)	(19.5m)	1.9m	7.0m	12.4m	1.4m	1.6m	(1.9m)
Accounts Payable	(2.7m)	3.6m	18.9m	4.4m	3.5m	2.1m	(1.9m)	(2.8m)	12.3m	4.3m	(2.0m)	2.9m	10.4m	20.7m
Cash From Operating Activities	(4.9m)	8.7m		3.8m	7.4m	13.9m	23.3m	24.6m	22.4m	27.0m	29.4m	8.4m	12.9m	28.7m
Purchases of PP&E	(7.1m)	(11.1m)		(6.7m)	(10.7m)	(3.5m)	(8.5m)	(14.5m)
Cash From Investing Activities	(26.7m)	(29.8m)		(8.8m)	(12.5m)	(9.4m)	(17.4m)	(32.4m)	(6.1m)	(15.7m)	(28.6m)	(8.7m)	(20.5m)	(33.4m)
Long-term Borrowings	(6.0m)	(7.1m)		(2.5m)	(4.0m)	(5.1m)	(6.4m)	(10.0m)	(1.3m)	(2.6m)	(8.4m)	(1.4m)	(2.8m)	(4.3m)
Cash From Financing Activities	42.1m	40.7m		11.5m	7.8m	(7.0m)	(5.1m)	8.4m	(11.7m)	(1.4m)	(6.9m)	(10.8m)	(9.7m)	8.1m
Interest Paid	573.0k	978.0k		897.0k	1.3m	517.0k	947.0k	1.4m
Income Taxes Paid	84.0k	86.0k			45.0k	367.0k	553.0k	3.3m	440.0k	4.6m	4.9m	8.0k	149.0k	163.0k